Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration's Approach for Its Product Labeling
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Peter R. Kowey Kenneth W Mahaffey Sean D Pokorney Laine Thomas Gregg C. Fonarow Eric D. Peterson Bernard J Gersh Jack Ansell Alan S Go Peter Shrader Daniel E. Singer Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators and Patients Jonathan P. Piccini Elaine Hylek |
| Publication date | October 1, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |